Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT)

Historical Holders from Q3 2016 to Q3 2025

Symbol
ADPT on Nasdaq
CUSIP
00650F109
Type / Class
Equity / Common stock, par value $0.0001 per share
Shares outstanding
152M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
148M
Holdings value
$1.73B
% of all portfolios
0.003%
Grand Portfolio weight change
0%
Number of holders
240
Number of buys
138
Number of sells
-88
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 6.7% $83.3M 9.94M BlackRock, Inc. Mar 31, 2025
Sumitomo Mitsui Trust Group, Inc. 4.6% $57.3M 6.83M Sumitomo Mitsui Trust Group, Inc. Dec 31, 2024
Nikko Asset Management Americas, Inc. 4.63% $57.3M 6.83M Nikko Asset Management Americas, Inc. Dec 31, 2024
INTEGRATED CORE STRATEGIES (US) LLC 4.3% $52.7M 6.29M Millennium Management LLC Dec 31, 2024
Rubric Capital Management LP 4.12% $58.1M 6.26M Rubric Capital Management LP Jun 30, 2025
ARK Investment Management LLC 2.9% -27.3% $40.9M -$15.5M 4.4M -27.5% ARK Investment Management LLC May 31, 2025

Institutional Holders of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 12.9K $194K +$239 $14.96 1
2025 Q2 148M $1.73B -$46.4M $11.65 240
2025 Q1 153M $1.14B +$68.7M $7.43 222
2024 Q4 143M $859M +$3.87M $6.00 204
2024 Q3 143M $732M -$27.7M $5.12 185
2024 Q2 149M $538M +$26.6M $3.62 174
2024 Q1 142M $456M -$10.6M $3.21 185
2023 Q4 269K $1.33M -$1.28M $4.90 4
2023 Q3 139M $759M +$15.5M $5.45 183
2023 Q2 136M $912M +$14.8M $6.71 204
2023 Q1 133M $1.17B +$16.7M $8.83 219
2022 Q4 132M $1.01B +$16.3M $7.64 211
2022 Q3 130M $926M -$29.7M $7.12 197
2022 Q2 124M $995M +$16.4M $8.09 189
2022 Q1 125M $1.74B -$39.5M $13.88 203
2021 Q4 123M $3.46B +$140M $28.06 205
2021 Q3 118M $4B -$423K $33.99 212
2021 Q2 117M $4.79B +$143M $40.86 225
2021 Q1 114M $4.58B -$120M $40.26 239
2020 Q4 114M $6.74B +$154M $59.13 241
2020 Q3 111M $5.41B +$508M $48.63 202
2020 Q2 99.9M $4.83B +$200M $48.38 187
2020 Q1 96.1M $2.67B +$278M $27.78 141
2019 Q4 86M $2.57B +$148M $29.92 126
2019 Q3 81M $2.49B +$38.9M $30.90 115
2019 Q2 78.2M $3.74B +$3.73B $48.30 109
2019 Q1 104K $4.25M $0 $40.86 1
2016 Q4 0 $0 -$10.1K 0
2016 Q3 235 $10.1K +$10.1K $43.05 1